1. Home
  2. RGTI vs AAPG Comparison

RGTI vs AAPG Comparison

Compare RGTI & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGTI
  • AAPG
  • Stock Information
  • Founded
  • RGTI 2013
  • AAPG 2009
  • Country
  • RGTI United States
  • AAPG China
  • Employees
  • RGTI N/A
  • AAPG 567
  • Industry
  • RGTI Retail: Computer Software & Peripheral Equipment
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • RGTI Technology
  • AAPG Health Care
  • Exchange
  • RGTI Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • RGTI 2.4B
  • AAPG 2.2B
  • IPO Year
  • RGTI N/A
  • AAPG 2025
  • Fundamental
  • Price
  • RGTI $10.58
  • AAPG $24.21
  • Analyst Decision
  • RGTI Strong Buy
  • AAPG Buy
  • Analyst Count
  • RGTI 4
  • AAPG 1
  • Target Price
  • RGTI $14.50
  • AAPG N/A
  • AVG Volume (30 Days)
  • RGTI 27.6M
  • AAPG 32.5K
  • Earning Date
  • RGTI 05-12-2025
  • AAPG 05-20-2025
  • Dividend Yield
  • RGTI N/A
  • AAPG N/A
  • EPS Growth
  • RGTI N/A
  • AAPG N/A
  • EPS
  • RGTI N/A
  • AAPG N/A
  • Revenue
  • RGTI $10,790,000.00
  • AAPG $134,352,180.00
  • Revenue This Year
  • RGTI $32.30
  • AAPG N/A
  • Revenue Next Year
  • RGTI $139.90
  • AAPG $389.09
  • P/E Ratio
  • RGTI N/A
  • AAPG N/A
  • Revenue Growth
  • RGTI N/A
  • AAPG 341.77
  • 52 Week Low
  • RGTI $0.66
  • AAPG $16.50
  • 52 Week High
  • RGTI $21.42
  • AAPG $26.50
  • Technical
  • Relative Strength Index (RSI)
  • RGTI 59.79
  • AAPG N/A
  • Support Level
  • RGTI $9.14
  • AAPG N/A
  • Resistance Level
  • RGTI $10.92
  • AAPG N/A
  • Average True Range (ATR)
  • RGTI 0.75
  • AAPG 0.00
  • MACD
  • RGTI 0.17
  • AAPG 0.00
  • Stochastic Oscillator
  • RGTI 87.84
  • AAPG 0.00

About RGTI Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: